Federal Supply Schedule 36F79724D015E

Award Date 2/16/24
Last Date to Order 8/14/24
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), is for the procurement of 65IB, Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Shorla Oncology Inc., a for-profit, foreign-owned organization. The contract has a ceiling value of $250,000.00 and a period of performance from August 15, 2024 to August 14, 2029. The contract aims to provide the VA with a range of pharmaceutical and hematology-related products. While no...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Autolus Inc., a foreign-owned for-profit organization, aims to procure drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $250,000.00 and a period of performance from March 4, 2025, to August 31, 2025. This is an interim agreement under FSS Schedule 65 I B, which covers the specified product categories. The...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Provepharm Inc., a foreign-owned, self-certified small disadvantaged business organization. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a performance period ending on March 15, 2023. It was awarded on October 10, 2022 and is not set aside...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at up to $25,000.00, is an interim agreement under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Iovance Biotherapeutics Manufacturing LLC, a for-profit organization. The contract has a period of performance lasting until October 14, 2024. No...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime contractor...
The Federal Supply Schedule (FSS) contract award 36F79724D0047 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,188,000.00 and a period of performance through December 31, 2028. The contract was awarded to Nnodum Pharmaceuticals Corp, a minority-owned and SBA-certified 8(a) small disadvantaged business. The contract is for the procurement of 65 I B, DRUGS,...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, aims to procure a variety of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $23,163,260.00 and a period of performance that extends through April 14, 2028. The prime contractor for this multiple-award FSS contract is Spectrum Pharmaceuticals, Inc., a for-profit organization and manufacturer of goods. The...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Aurobindo Pharma USA Inc., a foreign-owned for-profit organization. The contract was awarded on March 15, 2020, with a ceiling value of $700,000.00 and a period of performance ending on March 14, 2026. The contract scope covers the procurement of drugs, pharmaceuticals, and hematology-related products under the General Services...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, is an interim agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Genmab US Inc., a foreign-owned for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance through November 15, 2023. It was awarded on June 17, 2023 without any set-asides. The contract aims to...
  • 36F79724D015E
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Shorla Oncology Inc., a foreign-owned for-profit organization. The contract is for an interim agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products, with a ceiling value of $25,000.00 and a period of performance ending on August 14, 2024.

The contract does not have any set-asides and is a multiple award, meaning other vendors may also hold similar FSS contracts. As an FSS contract, it provides a pre-negotiated catalog of products and services that government agencies can order from, streamlining the procurement process. While the specific products and services were not provided, the contract's scope suggests it is focused on the delivery of drugs, pharmaceuticals, and hematology-related products to support the agency's healthcare operations and mission.

Generated 2/11/25, 10:09 AM